Ocular mantle cell lymphoma with aberrant CD10 expression: A potential diagnostic pitfall

Pathology

Volumn 41, Issue 7, 2009, Pages 704-706

  Lian, Derrick Wen Quan ^a   Chau, Yuk Ping ^a   Lee, Llewellyn Kuan Ming ^a   Teo, Clarence ^a   Yap, Wai Ming ^a   Chuah, Khoon Leong ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; PROTEIN BCL 2;

AGED; ANTIGEN EXPRESSION; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; EPITHELIOID CELL; EXOPHTHALMOS; EYE TUMOR; EYELID; FLUORESCENCE IN SITU HYBRIDIZATION; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND TUMOR; LETTER; MALE; MANTLE CELL LYMPHOMA; MICROSCOPY; MORPHOLOGY; NEUROLOGIC DISEASE; PHYSICAL EXAMINATION; SWELLING; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY; TUMOR VOLUME;

EID: 72749092225     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313020903306645     Document Type: Article

References (12)

1. Swerdlow SH, Campo E, Seto M, et al. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. 4th ed. Lyon: IARC Press, 2008; 229-232
2. Chan JKC. Tumors of the lymphoreticular system. In: Fletcher CDM, editor. Diagnostic Histopathology of Tumors. Philadelphia: Churchill Livingstone Elsevier, 2007: 1181-1184
3. Weisenburger DD. Mantle cell lymphoma. In: Knowles DM, editor. Neoplastic Hematopathology. 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 2001: 789.
4. Ferry J, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 2007; 31: 170-184
5. Yoo S, Kim YA, Jeon YK, et al. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma. A case report. Pathol Res Practice 2008; 204: 779-783
6. Zanetto U, Dong H, Huang Y, et al. Mantle cell lymphoma with aberrant expression of CD10. Histopathology 2008; 53: 20-29
7. Liu Z, Dong HY, Gorczyca W, et al. CD5-mantle cell lymphoma. Am J Clin Pathol 2002; 118: 216-224
8. Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol 2003; 119: 218-230
9. Sriganeshan V, Blom TR, Weissmann DJ. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology. Arch Pathol Lab Med 2008; 132: 1346-1349
10. Bookman MA, Lardelli P, Jaffe ES, et al. Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factors. J Natl Cancer Inst 1990; 82: 742-748 (Pubitemid 20159273)
11. Lardelli P, Bookman MA, Sundeen J, et al. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990; 14: 752-763 (Pubitemid 20233015)
12. Kelemen K, Peterson LC, Helenowski I, et al. CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease. Am J Clin Pathol 2008; 130: 166-177